FDA NDC Directory · JSON-LD · Markdown

NYPOZI txid

NDC 72374-101 · HUMAN PRESCRIPTION DRUG · INJECTION

Generic namefilgrastim-txid
Labeler / ManufacturerTanvex BioPharma USA, Inc.
Marketing categoryBiologic License Application · App BLA761126
Dosage form / routeINJECTION · INTRAVENOUS SUBCUTANEOUS
Active ingredientsFILGRASTIM (300 ug/300ug)
Marketing started20250923
Package count2

External sources

Source: openFDA. Public-domain (CC0).